Zydus Lifesciences acquires 50% stake in Sterling Biotech for fermentation-based protein business; shares drop nearly 6%

The joint venture aims to establish a “state-of-the-art” facility for manufacturing fermented animal-free protein for global markets.

Subscribe To Our Free Newsletter